Morgan Stanley
- SEC CIK
- 0000895421
- Latest filing
- Aug 13, 2026
ARTL holding history
Artelo Biosciences, Inc. in every 13F filed by Morgan Stanley, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ARTL overviewAll 13F holders of ARTLFull Q2 2026 holdings
- Shares (Q4 2025)
- 0
- Sold out in Q4 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 16
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2025 | 0 | $0 | 0.0% | −1,100−100.0% | Sold out | Holders |
| Q3 2025 | 1,100 | $5.05K | <0.1% | +1,096+27,400.0% | Added | Holders |
| Q2 2025 | 4 | $53 | <0.1% | −16−80.0% | Reduced | Holders |
| Q1 2025 | 20 | $18 | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2024 | 20 | $21 | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 20 | $22 | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 20 | $27 | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 20 | $30 | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 20 | $28 | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 20 | $29 | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 20 | $40 | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 20 | $46 | <0.1% | −5−20.0% | Reduced | Holders |
| Q4 2022 | 25 | $72 | <0.1% | +4+19.0% | Added | Holders |
| Q3 2022 | 21 | $0 | 0.0% | −279−93.0% | Reduced | Holders |
| Q2 2022 | 300 | $0 | 0.0% | 00.0% | Unchanged | Holders |
| Q1 2022 | 300 | $0 | 0.0% | +298+14,900.0% | Added | Holders |
| Q4 2021 | 2 | $0 | 0.0% | +2 | New | Holders |